Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Autoimmune Disease Diagnostics Market Share

Report ID: GMI618
   |
Published Date: September 2024
 | 
Report Format: PDF

Download free sample

Autoimmune Disease Diagnostics Market Share

The global market is highly competitive, characterized by rapid advancements in diagnostic technologies and a growing focus on early detection. Market players are continuously innovating to improve the accuracy, efficiency, and accessibility of diagnostic tests. The landscape is shaped by frequent product launches, strategic partnerships, and mergers and acquisitions aimed at expanding market presence. Additionally, increased investment in research and development, along with rising awareness of autoimmune diseases, is driving competition. The market is also influenced by regional expansions and the adoption of automation in diagnostic processes, further intensifying the competitive environment.
 

Autoimmune Disease Diagnostics Market Companies

Some of the eminent market participants operating in the autoimmune disease diagnostics industry include:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DIAsource ImmunoAssays SA
  • Euroimmun AG (Perkin Elmer)
  • F. Hoffmann-la Roche Ltd.
  • Hemagen Diagnostics
  • Myriad Genetics
  • Quest Diagnostics
  • Siemens Healthineers Inc
  • SQI Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc.
Authors: Mariam Faizullabhoy , Gauri Wani
Frequently Asked Question(FAQ) :
Who are the major autoimmune disease diagnostics industry players?
Abbott Laboratories, Bio-Rad Laboratories, Inc., DIAsource ImmunoAssays SA, Euroimmun AG (Perkin Elmer), F. Hoffmann-la Roche Ltd., Hemagen Diagnostics, Myriad Genetics, Quest Diagnostics, Siemens Healthineers Inc., SQI Diagnostics Inc., and Thermo Fisher Scientific Inc.
What is the size of the autoimmune disease diagnostics market?
How big is the North America autoimmune disease diagnostics market?
Why is the demand for autoimmune disease diagnostics rising in hospitals?

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    High incidence and prevalence of autoimmune diseases

3.2.1.2    Growing awareness about autoimmune diseases

3.2.1.3    Supportive government policies for research activities on autoimmune diseases

3.2.1.4    Technological advancements and increasing adoption of lab automation technologies

3.2.2    Industry pitfalls & challenges

3.2.2.1    Need for high capital investment in setting-up diagnosis centers

3.2.2.2    Slow turnaround time for test results and need for multiple diagnostic tests

3.3    Growth potential analysis

3.4    Technology landscape

3.5    Future market trends

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Reagents and consumables

5.3    Instruments

Chapter 6   Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Systemic autoimmune disease

6.2.1    Rheumatoid arthritis

6.2.2    Systemic lupus erythematosus (SLE)

6.2.3    Psoriasis

6.2.4    Multiple sclerosis

6.2.5    Other systemic autoimmune diseases

6.3    Localized autoimmune disease

6.3.1    Inflammatory bowel disease

6.3.2    Type 1 diabetes

6.3.3    Thyroid

6.3.4    Other localized autoimmune diseases

Chapter 7   Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Antinuclear antibody tests

7.3    Autoantibody tests

7.4    C-reactive protein (CRP)

7.5    Complete blood count (CBC)

7.6    Urinalysis

7.7    Other tests

Chapter 8   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Hospitals

8.3    Diagnostics centers

8.4    Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Rest of Latin America

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Abbott Laboratories

10.2    Bio-rad Laboratories, Inc.

10.3    DIAsource ImmunoAssays SA

10.4    Euroimmun AG (Perkin Elmer)

10.5    F. Hoffmann-la Roche Ltd.

10.6    Hemagen Diagnostics

10.7    Myriad Genetics

10.8    Quest Diagnostics

10.9    Siemens Healthineers Inc.

10.10    SQI Diagnostics Inc.

10.11    Thermo Fisher Scientific Inc.

10.12    Trinity Biotech Plc.

Authors: Mariam Faizullabhoy , Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 12

Tables & Figures: 234

Countries covered: 24

Pages: 190

Download Free Sample

Top